Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

NCT06377566

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: University of Miami Miami, Florida, United States

Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

View Trial Details

Recruiting

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

NCT07548697

Conditions: B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

NCT06263491

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

NCT07097363

Conditions: B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

NCT07546188

Conditions: Care Coordination, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium

View Trial Details

Recruiting

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

NCT03523975

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: City of Hope Medical center Duarte, California, United States

University of Michigan Ann Arbor, Michigan, United States

The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Recruiting

Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma

NCT07545603

Conditions: Follicular Lymphoma Grade 3A, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, +11 more
Locations: Beijing Cancer Hospitial Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

NCT06839053

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +25 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

NCT04544592

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, +20 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

View Trial Details

Recruiting

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT06859008

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +39 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions